https://www.selleckchem.com/pr....oducts/alpha-conotox
Expanding access to and utilization of naloxone is a vitally important harm reduction strategy for preventing opioid overdose deaths, particularly in vulnerable populations like Medicaid beneficiaries. The objective of this study was to characterize the landscape of monthly prescription fill limit policies in Medicaid programs and their potential implications for expanding naloxone use for opioid overdose harm reduction. A cross-sectional, multi-modal online and telephonic data collection strategy was used to identify and des